Menu

Virus May Explain “Melting” Sea Stars

Researchers discover a densovirus that is associated with sea star wasting disease.

Nov 19, 2014
Molly Sharlach

FLICKR, EARTHFIX, KATIE CAMPBELL

Along the Pacific coast of North America, sea stars have been dying off in record numbers since June 2013. The cause of sea star wasting disease, which transforms the animals into piles of mush, has been difficult to pin down. A study published this week (November 17) in PNAS points to a probable culprit: a single-stranded DNA virus known as a densovirus, related to viruses found in Hawaiian sea urchins.

Inspections of hundreds of infected tissues turned up no evidence of bacterial or eukaryotic pathogens, which led researchers to suspect a virus. A team led by scientists at Cornell University filtered extracts from sick sea stars to eliminate any infectious agents larger than viruses. They found that this filtrate caused healthy animals to develop the disease.

“When we inoculated them, they died within about a week to 14 days,” Cornell microbiologist Ian Hewson told Oregon Public Broadcasting’s EarthFix. “Whereas controls that had received viruses that had been destroyed by heat, did not become sick.”

Sequence analyses uncovered the densovirus, which turned out to be present in museum specimens dating back as far as 1942. Although sea star wasting disease has been observed in the past, this is the first time it has spread this widely and to such a range of species—at least 20 different taxa.

“This is probably the most extensive and devastating disease of marine invertebrates that has happened,” ecologist Bruce Menge of Oregon State University told Science. “It’s a major concern,” added Menge, who was not involved in the study.

The die-off has already led to increased populations of the sea stars’ prey, including barnacles and mussels, in many coastal areas. Researchers are continuing to examine whether factors such as increased ocean temperatures and acidification might contribute to the spread or severity of the disease.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.